ESPERITE : Extraordinary General Meeting of Shareholders 26 March 2020

February 13, 2020 Group News , Press Release (ENG)

ESPERITE N.V. convenes Extraordinary General Meeting of Shareholders on 26 March 2020

Amsterdam, The Netherlands – 13 February 2020

***

PDF Downloads – EGM 26 March 2020

           Press Release :  EGM-26-March-2020-Press-Release-1.pdf

          Agenda  :              EGM-26-March-2020-Agenda-1.pdf

          Notice  :                EGM-26-March-2020-Notice-1.pdf

Explanatory Notes :   EGM-26-March-2020-Explanatory-Notes-1.pdf

Power of Attorney :    EGM-26-March-2020-Power-of-Attorney-1.pdf

read more

Appointment of Ms. Karin Dorrepaal as non-executive director

May 22, 2012 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, is happy to welcome Ms. Karin Dorrepaal, PhD, MBA as its new Non-Executive Director.

Ms. Dorrepaal has been appointed at Cryo-Save’s Annual General Meeting held on May 16, 2012.

read more

EN – Appointment liquidity provider

August 6, 2010 Group News

Cryo-Save appoints Kempen & Co as liquidity provider

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, today announces that it has decided to appoint Kempen & Co as liquidity provider as of 2 August 2010.

With the appointment of a liquidity provider Cryo-Save aims to enhance the liquidity of its shares on Euronext Amsterdam.

read more

NL – Benoeming liquidity provider

August 6, 2010 Group News

Cryo-Save benoemt Kempen & Co als liquidity provider

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, maakt vandaag bekend Kempen & Co per 2 augustus 2010 te hebben benoemd als liquidity provider.

Met het aanstellen van een liquidity provider stelt Cryo-Save zich ten doel de liquiditeit van het aandeel op Euronext Amsterdam te vergroten.

read more

EN – Non-executive director appointment

March 19, 2010 Group News

Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, announces that Dr. Ronald H.W. Lorijn will be appointed as Non-Executive Director with effect from Cryo-Save’s AGM, which is expected to be on 19 May 2010, subject to shareholder approval.

read more

NL – Non-executive director appointment

March 19, 2010 Group News

Cryo-Save benoemt Ronald Lorijn tot Non-Executive director

Cryo-Save Group N.V. (AIM/Euronext: CRYO), Europa’s grootste stamcelbank, maakt bekend dat dr. Ronald H.W. Lorijn (58) (MD, PhD, MBA) tijdens de komende Algemene Vergadering van Aandeelhouders van de onderneming op 19 mei aanstaande zal worden voorgedragen voor benoeming tot Non-Executive Director en lid van de Board van Cryo-Save Group.

read more

EN – New CEO appointment

February 4, 2010 Group News

Arnoud van Tulder appointed Chief Executive

Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, has appointed Arnoud van Tulder (48) as Chief Executive Officer with effect from 1 May 2010. Arnoud, currently Chief Financial Officer of Cryo-Save, will succeed Marc Waeterschoot (60), who will remain on the Board as an Executive Director.

read more

NL – New CEO appointment

February 4, 2010 Group News

Arnoud van Tulder nieuwe CEO Cryo-Save Group

Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, kondigt aan dat Arnoud van Tulder (48), momenteel Chief Financial Officer van de Groep, met ingang van 1 mei 2010 zal worden benoemd tot Chief Executive Officer. Arnoud van Tulder zal Marc Waeterschoot (60) opvolgen, die evenwel aanblijft als Executive Director in de Board of Directors.

read more